Valneva is involved in health conferences in the United States and Europe

Valneva, a company specializing in vaccines, is participating in several health conferences in October and November 2026. Based in Lyon, it aims to showcase its activities and meet institutional investors in Europe and the United States.

Valneva's leaders will highlight the company's value creation drivers and present upcoming catalysts, particularly for their Lyme disease vaccine candidate, developed in partnership with Pfizer. Regulatory decisions for this vaccine are expected in the coming months.

Valneva will also present the progress of its R&D portfolio at events in Paris, Boston, New York and London, centered around interactive discussions and meetings with investors.